Nkd2 (NM_028186) Mouse Tagged ORF Clone Lentiviral Particle

CAT#: MR207371L3V

  • LentiORF®

Lenti ORF particles, Nkd2 (Myc-DDK-tagged) - Mouse naked cuticle 2 homolog (Drosophila) (Nkd2), 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 9,025.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (2)
Lenti ORF control particles of pLenti-C-Myc-DDK-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name Nkd2 (NM_028186) Mouse Tagged ORF Clone Lentiviral Particle
Synonyms 2210403L10Rik; AW212591; mNkd2
Vector pLenti-C-Myc-DDK-P2A-Puro
ACCN NM_028186
ORF Size 1386 bp
Sequence Data
The ORF insert of this clone is exactly the same as(MR207371).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_028186.2
RefSeq Size 3222 bp
RefSeq ORF 1386 bp
Locus ID 72293
Gene Summary Cell autonomous antagonist of the canonical Wnt signaling pathway. May activate a second Wnt signaling pathway that controls planar cell polarity. Required for processing of TGFA and for targeting of TGFA to the basolateral membrane of polarized epithelial cells (By similarity).[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...